Skip to search formSkip to main contentSkip to account menu

esaprazole

Known as: N-((N-cyclohexylcarbamoyl)methyl)piperazine, hexaprazol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The effects of esaprazole, a novel antiulcer drug, on gastric acid secretion and plasma gastrin levels were investigated in dogs… 
1993
1993
To study the effect of Esaprazole, a new antiulcer drug, on acid, peptic and alkaline secretion a modified gastric acid test was… 
1992
1992
The effects of esaprazole on gastric secretion (volume, pepsin and acid output) were investigated on animal models, both in vivo… 
1989
1989
Thirteen healthy control subjects were studied in order to evaluate any effect of acute hexaprazol injection on some… 
1987
1987
The activity and tolerability of esaprazole administered once a day at doses of 900 and 1350 mg/day in the treatment of gastric… 
1986
1986
The potential protective properties of esaprazole on the gastric mucosa following administration of aspirin were evaluated by… 
1985
1985
Hexaprazol was tested against the gastric barrier breaking effect of aspirin (ASA), using the electric potential difference (PD…